Nelson B Rodrigues Selected Research

Ketamine

1/2024	Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression.
10/2023	Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression.
1/2023	Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth.
1/2023	Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder.
1/2023	Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression.
12/2022	The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review.
1/2022	Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.
1/2022	Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis.
1/2022	Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence.
1/2022	Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nelson B Rodrigues Research Topics

Disease

32	Treatment-Resistant Depressive Disorder 01/2024 - 01/2020
16	Major Depressive Disorder (Major Depressive Disorders) 01/2024 - 01/2020
15	Bipolar Disorder (Manic Depressive Psychosis) 10/2023 - 01/2020
8	Mood Disorders (Mood Disorder) 01/2022 - 11/2020
2	Anhedonia 01/2022 - 11/2020
2	Hypertension (High Blood Pressure) 11/2021 - 01/2021
2	Inflammation (Inflammations) 04/2021 - 01/2020
1	Post-Acute COVID-19 Syndrome 01/2023
1	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2022
1	Neurobehavioral Manifestations 10/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Psychomotor Agitation (Akathisia) 01/2022
1	Tardive Dyskinesia 12/2021
1	Pain (Aches) 11/2021
1	Dysuria 04/2021
1	Hematuria 04/2021
1	Headache (Headaches) 01/2021
1	Insulin Resistance 01/2021
1	Nausea 01/2021
1	COVID-19 01/2021
1	Mental Disorders (Mental Disorder) 12/2020
1	Weight Gain 11/2020
1	Weight Loss (Weight Reduction) 11/2020
1	Psychotic Disorders (Schizoaffective Disorder) 08/2020
1	Mania (Manias) 08/2020
1	Cognitive Dysfunction 09/2018

Drug/Important Bio-Agent (IBA)

39	Ketamine FDA LinkGeneric 01/2024 - 01/2020
20	Antidepressive Agents (Antidepressants)IBA 01/2024 - 01/2020
6	EsketamineIBA 12/2022 - 01/2021
3	Psilocybin (Psilocibin)IBA 01/2022 - 12/2020
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 11/2021
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2024 - 11/2021
2	Anesthetics (Anesthetic Agents)IBA 11/2021 - 04/2021
1	VaccinesIBA 01/2023
1	Infliximab (Remicade)FDA Link 11/2022
1	Therapeutic UsesIBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 12/2021
1	PlacebosIBA 10/2021
1	Immunoglobulin E (IgE)IBA 04/2021
1	VortioxetineIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Hallucinogens (Psychedelics)IBA 12/2020
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 12/2020
1	Serotonin (5 Hydroxytryptamine)IBA 11/2020
1	Histamine (Histamine Dihydrochloride)FDA Link 11/2020
1	Bupropion (Wellbutrin)FDA LinkGeneric 11/2020
1	Mirtazapine (Rexer)FDA LinkGeneric 11/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2021
1	Anesthesia 11/2021
1	Pain Management 11/2021
1	Transcranial Magnetic Stimulation 10/2021
1	Combined Modality Therapy 09/2018